DHODH and neoplasm: In addition, studies in cell lines and animal models have shown that MEN1 mutations lead to an upregulation of the enzyme dihydroorotate dehydrogenase (DHODH), and administration of the DHODH inhibitor, leflunomide, attenuates cell growth and tumor progression [80].